Massive 10,000-Person study tracks eczema drug results
NCT ID NCT04504955
Summary
This study is creating a large national registry to track how well approved eczema (atopic dermatitis) treatments work and how safe they are in real-world settings. It will follow 10,000 adult patients under the care of a dermatologist who are starting a new medication. The goal is to collect detailed information on treatment outcomes, side effects, and how the disease affects daily life over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.